Yaya Chu

Targeting CD20+ Aggressive B-cell Non–Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells <i>In Vitro</i> and in NSG Mice

Yaya Chu, Jessica Hochberg, Ashlin Yahr et al. · Cancer Immunology Research · 2014 · 168 citations · Full text

Expbnk-treated Mice, Immunology, Immune Regulation +17

Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma <i>in vitro</i> and in immunodeficient mice

Yaya Chu, Ashlin Yahr, Brian Z. Huang et al. · OncoImmunology · 2017 · 78 citations · Full text

Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2⁺ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice

Yaya Chu, Gaurav Nayyar, Susiyan Jiang et al. · Journal for ImmunoTherapy of Cancer · 2021 · 37 citations · Full text

Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity

Prakash Satwani, Sejal Bavishi, Aniket Saha et al. · Cytotherapy · 2014 · 29 citations

Cancer Immunosurveillance, Non-hodgkin Lymphoma Cells, Immunology +7

Ibrutinib significantly inhibited Bruton’s tyrosine kinase (BTK) phosphorylation,<i>in-vitro</i> proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model

Yaya Chu, Sanghoon Lee, Tishi Shah et al. · OncoImmunology · 2018 · 22 citations · Full text